Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00558792 · ClinicalTrials.gov registry record · Phase 2
Coronary MDCTA With Iopamidol Injection 370
A Phase 2 study, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
NCT00558792 is a Phase 2 study that has completed, run by Bracco Diagnostics. The registered enrollment target is 210 participants.
The verdict
NCT00558792, a Phase 2 study, has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
Study Summary
Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.
Interventions
- DRUG Isovue 370, 70 mL
- DRUG Isovue 370, 80 mL
- DRUG Isovue 370, 90 mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00558792
The ClinicalTrials.gov registry entry for NCT00558792 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bracco Diagnostics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Isovue 370, 70 mL is the first listed.
NCT00558792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00558792 about?
NCT00558792 is a clinical study titled "Coronary MDCTA With Iopamidol Injection 370". Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.
What is the current status of trial NCT00558792?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2007-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00558792?
The interventions under investigation include: Isovue 370, 70 mL (DRUG), Isovue 370, 80 mL (DRUG), Isovue 370, 90 mL (DRUG).
Who is sponsoring clinical trial NCT00558792?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.